vs
Side-by-side financial comparison of Incyte (INCY) and OCEANEERING INTERNATIONAL INC (OII). Click either name above to swap in a different company.
Incyte is the larger business by last-quarter revenue ($1.3B vs $692.4M, roughly 1.8× OCEANEERING INTERNATIONAL INC). Incyte runs the higher net margin — 23.8% vs 5.2%, a 18.6% gap on every dollar of revenue. On growth, Incyte posted the faster year-over-year revenue change (20.9% vs 3.6%). Over the past eight quarters, Incyte's revenue compounded faster (10.4% CAGR vs 1.8%).
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Oceaneering International, Inc. is a subsea engineering and applied technology company based in Houston, Texas, U.S. that provides engineered services and hardware to customers who operate in marine, space, and other environments.
INCY vs OII — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $692.4M |
| Net Profit | $303.3M | $36.1M |
| Gross Margin | — | — |
| Operating Margin | 23.7% | — |
| Net Margin | 23.8% | 5.2% |
| Revenue YoY | 20.9% | 3.6% |
| Net Profit YoY | 91.7% | -28.3% |
| EPS (diluted) | $1.47 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $692.4M | ||
| Q4 25 | $1.5B | $668.6M | ||
| Q3 25 | $1.4B | $742.9M | ||
| Q2 25 | $1.2B | $698.2M | ||
| Q1 25 | $1.1B | $674.5M | ||
| Q4 24 | $1.2B | $713.5M | ||
| Q3 24 | $1.1B | $679.8M | ||
| Q2 24 | $1.0B | $668.8M |
| Q1 26 | $303.3M | $36.1M | ||
| Q4 25 | $299.3M | $177.7M | ||
| Q3 25 | $424.2M | $71.3M | ||
| Q2 25 | $405.0M | $54.4M | ||
| Q1 25 | $158.2M | $50.4M | ||
| Q4 24 | $201.2M | $56.1M | ||
| Q3 24 | $106.5M | $41.2M | ||
| Q2 24 | $-444.6M | $35.0M |
| Q1 26 | — | — | ||
| Q4 25 | 92.0% | 19.8% | ||
| Q3 25 | 92.8% | 20.6% | ||
| Q2 25 | 93.5% | 21.3% | ||
| Q1 25 | 93.0% | 20.0% | ||
| Q4 24 | 92.5% | 19.9% | ||
| Q3 24 | 92.4% | 19.3% | ||
| Q2 24 | 92.7% | 18.0% |
| Q1 26 | 23.7% | — | ||
| Q4 25 | 22.3% | 9.8% | ||
| Q3 25 | 32.5% | 11.6% | ||
| Q2 25 | 43.6% | 11.3% | ||
| Q1 25 | 19.5% | 10.9% | ||
| Q4 24 | 25.6% | 10.9% | ||
| Q3 24 | 12.8% | 10.5% | ||
| Q2 24 | -45.8% | 9.0% |
| Q1 26 | 23.8% | 5.2% | ||
| Q4 25 | 19.9% | 26.6% | ||
| Q3 25 | 31.1% | 9.6% | ||
| Q2 25 | 33.3% | 7.8% | ||
| Q1 25 | 15.0% | 7.5% | ||
| Q4 24 | 17.1% | 7.9% | ||
| Q3 24 | 9.4% | 6.1% | ||
| Q2 24 | -42.6% | 5.2% |
| Q1 26 | $1.47 | $0.36 | ||
| Q4 25 | $1.46 | $1.75 | ||
| Q3 25 | $2.11 | $0.71 | ||
| Q2 25 | $2.04 | $0.54 | ||
| Q1 25 | $0.80 | $0.49 | ||
| Q4 24 | $0.90 | $0.55 | ||
| Q3 24 | $0.54 | $0.40 | ||
| Q2 24 | $-2.04 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | $488.8M |
| Stockholders' EquityBook value | $5.6B | $1.1B |
| Total Assets | $7.3B | $2.6B |
| Debt / EquityLower = less leverage | — | 0.44× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.1B | $695.9M | ||
| Q3 25 | $2.5B | $7.0M | ||
| Q2 25 | $2.0B | $7.0M | ||
| Q1 25 | $1.9B | $7.0M | ||
| Q4 24 | $1.7B | $504.5M | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $987.3M | — |
| Q1 26 | — | $488.8M | ||
| Q4 25 | — | $487.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $482.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $5.6B | $1.1B | ||
| Q4 25 | $5.2B | $1.1B | ||
| Q3 25 | $4.7B | $907.7M | ||
| Q2 25 | $4.2B | $842.1M | ||
| Q1 25 | $3.7B | $773.1M | ||
| Q4 24 | $3.4B | $714.3M | ||
| Q3 24 | $3.2B | $698.0M | ||
| Q2 24 | $3.0B | $651.0M |
| Q1 26 | $7.3B | $2.6B | ||
| Q4 25 | $7.0B | $2.7B | ||
| Q3 25 | $6.3B | $2.5B | ||
| Q2 25 | $5.8B | $2.3B | ||
| Q1 25 | $5.7B | $2.3B | ||
| Q4 24 | $5.4B | $2.3B | ||
| Q3 24 | $5.0B | $2.4B | ||
| Q2 24 | $4.7B | $2.3B |
| Q1 26 | — | 0.44× | ||
| Q4 25 | — | 0.46× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.67× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | — |
| Free Cash FlowOCF − Capex | — | $-76.5M |
| FCF MarginFCF / Revenue | — | -11.1% |
| Capex IntensityCapex / Revenue | — | 2.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $238.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $543.3M | $221.1M | ||
| Q3 25 | $559.4M | $101.3M | ||
| Q2 25 | $44.7M | $77.2M | ||
| Q1 25 | $266.1M | $-80.7M | ||
| Q4 24 | $381.2M | $128.4M | ||
| Q3 24 | $310.9M | $91.9M | ||
| Q2 24 | $-575.6M | $52.6M |
| Q1 26 | — | $-76.5M | ||
| Q4 25 | — | $190.7M | ||
| Q3 25 | — | $77.0M | ||
| Q2 25 | — | $46.9M | ||
| Q1 25 | — | $-106.8M | ||
| Q4 24 | — | $94.5M | ||
| Q3 24 | — | $67.0M | ||
| Q2 24 | — | $29.8M |
| Q1 26 | — | -11.1% | ||
| Q4 25 | — | 28.5% | ||
| Q3 25 | — | 10.4% | ||
| Q2 25 | — | 6.7% | ||
| Q1 25 | — | -15.8% | ||
| Q4 24 | — | 13.2% | ||
| Q3 24 | — | 9.9% | ||
| Q2 24 | — | 4.5% |
| Q1 26 | — | 2.5% | ||
| Q4 25 | — | 4.6% | ||
| Q3 25 | — | 3.3% | ||
| Q2 25 | — | 4.3% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | — | 4.7% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | — | 3.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.82× | 1.24× | ||
| Q3 25 | 1.32× | 1.42× | ||
| Q2 25 | 0.11× | 1.42× | ||
| Q1 25 | 1.68× | -1.60× | ||
| Q4 24 | 1.89× | 2.29× | ||
| Q3 24 | 2.92× | 2.23× | ||
| Q2 24 | — | 1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
